Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Status:
Terminated
Trial end date:
2019-07-03
Target enrollment:
Participant gender:
Summary
This trial seeks to describe the effect of withdrawal from mycophenolate mofetil (MMF) on
risk of clinically significant disease reactivation in quiescent SLE patients who have been
on long-term MMF therapy.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators:
Autoimmunity Centers of Excellence Rho Federal Systems Division, Inc.